CLASS II Drug recall · Reported 19 Jun 2019 · FDA Enforcement Report

Children's Mapap Acetaminophen Liquid, Fever reducer recalled

Torrent Pharma is recalling Children's Mapap Acetaminophen Liquid, Fever reducer, Pain reliever, Alcohol free, distributed nationwide in the US. The recall was initiated on 21 May 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #s: a) 17E003; 17E038, Exp. 05/2019; 17F002; 17F005; 17F007; 17F025, Exp. 06/2019; 17G014, Exp. 07/2019; 17H015, Exp. 08/2019; 17J004; 17J006; 17J016, Exp. 09/2019; 17K008; 17K013; 17K021; 17K027, Exp. 10/2019; 17L021, Exp. 11/2019; 17M032, Exp. 12/2019; 18A023; 18A039, Exp. 01/2020; 18B007; 18B030; 18B037, Exp. 02/2020; 18C017; 18C026, Exp. 03/2020; 18D003; 18D034, Exp. 04/2020; 18E027; 18E033, Exp. 05/2020; 18F024; 18F033, Exp. 06/2020; 18G001; 18G023, Exp. 07/2020; 18J008; 18J009; 18J017; 18J027, Exp. 09/2020; 18K013; 18K014; 18K028, Exp. 10/2020. b) 17E006; 17E008, Exp. 05/2019; 17G001; 17G008;17G025, Exp. 07/2019; 17J022, Exp. 09/2019; 17K001; 17K007; 17K007A, Exp. 10/2019; 17L014, 17L034, Exp. 11/2019; 18A007; 18A007A, Exp. 01/2020; 18A025; 18A036, Exp. 01/2020; 18B018; 18B033; 18B034, Exp. 02/2020; 18D032; 18D035, Exp. 04/2020; 18E006; 18E035; 18E036, Exp. 05/2020; 18F033; 18F034, Exp. 06/2020; 18G007; 18G019, Exp. 07/2020; 18H008; 18H009; 18H025, Exp. 08/2020; 19A002, Exp. 01/2021.

Quantity recalled2,646,228 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number: D-1348-2019
FDA event ID: 82889
Recalling firm: Torrent Pharma, Levittown, PA
Classification: Class II
Status: Terminated
Recall initiated: 21 May 2019
FDA classified: 13 Jun 2019
Reported: 19 Jun 2019
Type: Voluntary: Firm initiated
Customers notified by: Letter
Reason category: Sterility
Drug class: Pain Medication

Timeline

21 May 2019	Recall initiated by company
13 Jun 2019	Classified by FDA	+23 days
19 Jun 2019	Published in enforcement report	+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Children's Mapap Acetaminophen Liquid, Fever reducer, Pain reliever, Alcohol free, Aspirin free, Cherry flavored, acetaminophen 160 mg per 5 mL, a) 4 FL. oz. (118 mL) bottle, NDC 0904-1985-20, b) One Pint (473 mL) bottle, NDC: 0904-1985-16, Distributed by Major Pharmaceuticals, Livonia MI 48152.

Where it was distributed

Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.

Nationwide

Questions about this recall

Is Children's Mapap Acetaminophen Liquid, Fever reducer, Pain reliever, Alcohol free recalled?

Yes. Torrent Pharma recalled Children's Mapap Acetaminophen Liquid, Fever reducer, Pain reliever, Alcohol free on 21 May 2019. The recall is Class II and its status is Terminated. Recall number D-1348-2019.

Why was it recalled?

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Which lots are affected?

Lot #s: a) 17E003; 17E038, Exp. 05/2019; 17F002; 17F005; 17F007; 17F025, Exp. 06/2019; 17G014, Exp. 07/2019; 17H015, Exp. 08/2019; 17J004; 17J006; 17J016, Exp. 09/2019; 17K008; 17K013; 17K021; 17K027, Exp. 10/2019; 17L021, Exp. 11/2019; 17M032, Exp. 12/2019; 18A023; 18A039, Exp. 01/2020; 18B007; 18B030; 18B037, Exp. 02/2020; 18C017; 18C026, Exp. 03/2020; 18D003; 18D034, Exp. 04/2020; 18E027; 18E033, Exp. 05/2020; 18F024; 18F033, Exp. 06/2020; 18G001; 18G023, Exp. 07/2020; 18J008; 18J009; 18J017; 18J027, Exp. 09/2020; 18K013; 18K014; 18K028, Exp. 10/2020. b) 17E006; 17E008, Exp. 05/2019; 17G001; 17G008;17G025, Exp. 07/2019; 17J022, Exp. 09/2019; 17K001; 17K007; 17K007A, Exp. 10/2019; 17L014, 17L034, Exp. 11/2019; 18A007; 18A007A, Exp. 01/2020; 18A025; 18A036, Exp. 01/2020; 18B018; 18B033; 18B034, Exp. 02/2020; 18D032; 18D035, Exp. 04/2020; 18E006; 18E035; 18E036, Exp. 05/2020; 18F033; 18F034, Exp. 06/2020; 18G007; 18G019, Exp. 07/2020; 18H008; 18H009; 18H025, Exp. 08/2020; 19A002, Exp. 01/2021.

Where was it sold?

Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Torrent Pharma

All 84

Reported	Class	Recall	Company	Reason	Where
11 Jun 2025Drug	CLASS II	Fluoxetine Tablets, USP, 20 mg recalled by Torrent PharmaFluoxetine	Torrent Pharma	Nitrosamine Impurity	Nationwide
11 Jun 2025Drug	CLASS II	Fluoxetine Tablets, USP, 20 mg Carton ( Unit-dose) recalledFluoxetine	Torrent Pharma	Nitrosamine Impurity	Nationwide
11 May 2022Drug	CLASS II	Pantoprazole Sodium Delayed-Release Tablets, USP, 20 mg recalledPantoprazole Sodium	Torrent Pharma	Manufacturing (CGMP) Deviations	Nationwide
19 Jan 2022Drug	CLASS II	Carbamazepine Tablets, USP 200 mg recalled by Torrent PharmaCarbamazepine	Torrent Pharma	Potency & Assay	Nationwide
22 Dec 2021Drug	CLASS III	Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg recalled	Torrent Pharma	Potency & Assay	Nationwide